Abstract |
To identify topically effective EP4 agonists and EP2/EP4 dual agonists with excellent subtype selectivity, further optimization of the 16-phenyl ω-chain moiety of the γ- lactam 5-thia prostaglandin E analog and the 2-mercaptothiazole-4-carboxylic acid analog were undertaken. Rat in vivo evaluation of these newly identified compounds as their poly (lactide-co-glycolide) microsphere formulation, from which sustained release of the test compound is possible, led us to discover compounds that showed efficacy in a rat bone fracture healing model after its topical administration without serious influence on blood pressure and heart rate. A structure-activity relationship study is also presented.
|
Authors | Tohru Kambe, Toru Maruyama, Yoshihiko Nakai, Hiroji Oida, Takayuki Maruyama, Nobutaka Abe, Akio Nishiura, Hisao Nakai, Masaaki Toda |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 20
Issue 11
Pg. 3502-22
(Jun 01 2012)
ISSN: 1464-3391 [Electronic] England |
PMID | 22546206
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- 2-mercaptothiazole-4-carboxylic acid
- Delayed-Action Preparations
- Lactams
- Prostaglandins E, Synthetic
- Receptors, Prostaglandin E, EP2 Subtype
- Receptors, Prostaglandin E, EP4 Subtype
- Thiazolidines
- Polyglactin 910
- Dinoprostone
|
Topics |
- Administration, Topical
- Animals
- Blood Pressure
(drug effects)
- CHO Cells
- Cricetinae
- Delayed-Action Preparations
(administration & dosage, chemistry)
- Dinoprostone
(chemistry)
- Drug Evaluation, Preclinical
(methods)
- Fracture Healing
(drug effects)
- Heart Rate
(drug effects)
- Lactams
(administration & dosage, chemical synthesis, pharmacology)
- Male
- Mice
- Microspheres
- Molecular Structure
- Polyglactin 910
(administration & dosage, chemistry)
- Prostaglandins E, Synthetic
(chemical synthesis, pharmacology)
- Rats
- Rats, Sprague-Dawley
- Receptors, Prostaglandin E, EP2 Subtype
(agonists)
- Receptors, Prostaglandin E, EP4 Subtype
(agonists)
- Structure-Activity Relationship
- Thiazolidines
(chemistry)
|